http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2407355-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6420d04b0d68f339771080e32bd0fbc9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-971 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-106664 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 |
| filingDate | 2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7eaa6ba89b3f9481e030e477b755f7a |
| publicationDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2407355-T3 |
| titleOfInvention | Test to measure factor VIIa-antithrombin complexes |
| abstract | Method for measuring the concentration of factor VIIa-antithrombin complexes in a plasma sample of a patient comprising the following steps: mixing an amount of said plasma sample with a primary capture antibody fixed to a solid phase, said primary antibody being characterized because it has a binding capacity a) to the factor VIIa part or b) to the antithrombin part of the factor VIIa-antithrombin complexes that may be present in said plasma sample, and incubated the mixture under conditions that promote the union between said capture antibody and said factor VIIa-antithrombin complexes that could be present in said plasma sample to form bound VIIa-antithrombin complexes and an unbound mixture; extract said unbound sample; mixing said bound factor VIIa-antithrombin complexes with a secondary antibody characterized in that it presents a binding capacity a) to the antithrombin part b) to the factor VIIa part, respectively, of said bound factor VIIa-antithrombin complexes to form complexes of bound secondary VIIa-antithrombin antibody and a mixture of unbound secondary antibody; extract any mixture of unbound secondary antibody; determine the amount of bound secondary antibody; and comparing the amount of bound secondary antibody with a standard amount of bound bound secondary antibody for bound factor VIIa-antithrombin complexes of a known concentration. |
| priorityDate | 2001-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.